0001209191-19-058314.txt : 20191127
0001209191-19-058314.hdr.sgml : 20191127
20191127155345
ACCESSION NUMBER: 0001209191-19-058314
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191126
FILED AS OF DATE: 20191127
DATE AS OF CHANGE: 20191127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith David V
CENTRAL INDEX KEY: 0001229447
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 191257639
MAIL ADDRESS:
STREET 1: 6035 STONERIDGE DRIVE
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER NAME:
FORMER CONFORMED NAME: SMITH DAVID V
DATE OF NAME CHANGE: 20030429
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
DATE OF NAME CHANGE: 20020613
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-26
0
0001175505
FIVE PRIME THERAPEUTICS, INC.
FPRX
0001229447
Smith David V
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Executive Vice President & CFO
Common Stock
2019-11-26
4
F
0
6611
3.77
D
33389
D
/s/ Francis Sarena, Attorney-in-fact
2019-11-27